KLRK1 and glioblastoma: Platelets and their aggregates may favor tumor progression by facilitating NF-Κb mediated epithelial-mesenchymal transition, protecting tumor cells from immune surveillance via TGF-β mediated down regulation of NKG2D on the surface of NK-cells, and direct protection of GBM cells via cloak formation [41–44].